← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ancora Pharmaceuticals, Inc.
Medford, MA
$4,414,961
Total funding
5
Grants
Funding over time
peak $1.2M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,414,961 · 5
By mechanism
R44$3,320,986 · 1
R43$794,727 · 3
N43$299,248 · 1
Investigators at Ancora Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an anti-malaria toxin vaccine candidate$1,186,750
R44 · FY2007 · AI
Development of an anti-malaria toxin vaccine candidate$1,067,392
R44 · FY2006 · AI
Development of an anti-malaria toxin vaccine candidate$1,066,844
R44 · FY2005 · AI
SYNTHESIS OF GLYCOSAMINOGLYCANS$299,248
N43 · FY2013 · CA
Evaluation of a synthetic anti-GPI vaccine candidate in severe anemia models of m$266,867
R43 · FY2009 · AI
Evaluation of a synthetic anti-GPI vaccine candidate in severe anemia models of m$264,110
R43 · FY2010 · AI
Synthesis &Characterization of a Tuberculosis Vaccine$133,000
R43 · FY2004 · AI
Synthesis and Optimization of a Malaria Vaccine$130,750
R43 · FY2004 · AI